Immediate Impact
10 from Science/Nature 58 standout
Citing Papers
Lipoprotein(a) and cardiovascular disease
2024 Standout
Oral Muvalaplin for Lowering of Lipoprotein(a)
2024 Standout
Works of U Neyer being referenced
Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis.
1995
Apolipoprotein(a) phenotypes predict the risk for carotid atherosclerosis in patients with end-stage renal disease.
1994
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| U Neyer | 159 | 61 | 240 | 152 | 15 | 469 | |
| Paul Leurs | 177 | 62 | 109 | 94 | 16 | 418 | |
| J.W. Persaud | 169 | 32 | 192 | 188 | 20 | 464 | |
| C Hottelart | 162 | 67 | 138 | 123 | 15 | 420 | |
| Paul Altmann | 128 | 53 | 150 | 50 | 12 | 493 | |
| Cheng-Hsueh Wu | 53 | 52 | 154 | 153 | 22 | 439 | |
| Zachariah Varghese | 150 | 34 | 143 | 150 | 12 | 443 | |
| R Takeda | 72 | 59 | 211 | 152 | 26 | 452 | |
| B Angelkort | 133 | 104 | 123 | 211 | 32 | 535 | |
| JS Yudkin | 62 | 60 | 99 | 238 | 27 | 552 | |
| Kevin Douglas | 108 | 26 | 192 | 74 | 14 | 470 |
All Works
Loading papers...